A novel skeletal norhumulene (1) and six xeniaphyllane-derived compounds, including norditerpenoids (2, 3) and diterpenoids (4-7), were isolated from the EtOAc extract of the Formosan soft coral Sinularia gibberosa. Their structures were elucidated by spectroscopic analysis. In vitro cytotoxic evaluation of the above metabolites revealed that 2 and 4 showed weak cytotoxicity toward a few cancer cell lines.
Our previous study on the secondary metabolites of a Formosan soft coral Sinularia gibberosa TIXIER-DURIVAULT (Alcyoniidae) has resulted in the isolation of a series of bcaryophyllene-related metabolites and xeniaphyllane-related metabolites. [1] [2] [3] Some of these metabolites have been shown to exhibit cytotoxicity toward several caner cell lines. 1, 3) Our continuing investigation on the chemical constituents of this soft coral has again led to the isolation of one novel norhumulene 1, two new norxeniaphyllanes 2 and 3, three new xeniaphyllanes 4-6, and a new xeniaphyllane-derived diterpenoid 7 possessing a rare cyclic peroxyhemiketal (3,6-dihydro-1,2-dioxin-3-ol). 2, 4) We describe herein the isolation, structure elucidation and biological activity of these compounds.
The minced bodies of S. gibberosa were extracted exhaustively with EtOAc. The combined extract was concentrated under reduced pressure, and the residue was fractionated by open column chromatography on silica gel. The terpenoidcontaining fractions (characterized by 1 Fig. 1 . The olefinic methyls (d H 1.49, s and 1.59, s) attached at C-4 and C-11 were confirmed by HMBC correlations from H 3 -13 to C-3, C-4, and C-5 and H 3 -12 to C-1, C-10, and C-11, respectively. The hydroxy group was determined to be located at C-9 due to the HMBC correlations observed from H 2 -14 (d 5.09, s and 5.29, s) and H 2 -10 (d 2.02, m and 2.56, dd, Jϭ12.0, 4.0) to C-9 (d 74.8, CH). Thus, two methyl-containing double bonds and a hydroxy group were positioned at C-1/C-11, C-4/C-5 and C-9, respectively. The structure of 1 was thus established as a norhumulene. On the basis of above results, the structure of 1 was established as 9-hydroxy-13-norhumulene-1E,4E,8(14)-triene.
Gibberosin O (2) was found to possess a molecular formula C 21 H 32 O 4 from the pseudomolecular ion peak appearing at m/z 371.2197 [MϩNa] ϩ in the HR-ESI-MS, corresponding to six degrees of unsaturation. Fig. 1 . Accordingly, the C-5 and C-12 positions of two keto-carbonyls 2 were interpreted by the HMBC 3, CH) . Thus, the norxeniaphyllane framework of metabolite 2 and the lack of one methyl group at C-15 relative to other xeniaphyllane diterpenoids 1,2,5) were suggested. The relative stereochemistry of the four chiral centers at C-1, C-4, C-9, and C-11 in 2 was established on the basis of the NOE correlations (Fig. 2) observed in the NOESY spectrum. Assuming the b orientation of H-9, 1,2) it was found that H-9 exhibited NOE correlations with H-4, H-10b (d 1.68, m) and H 3 -18, but not with H-1 (d 1.98, m), and H 3 -20, while H-3a (d 1.65, m) displayed NOE interaction with H-1 and H 3 -20. These observations suggested that H-1, and H 3 -20 should be a-oriented. On the basis of the above findings and other detailed NOE interactions (Fig. 2) , the relative structure of compound 2 was unambiguously established as (1S*,4S*,9R*,11S*)-15-acetoxy-16-norxeniaphylla-8(19)-en-5,12-dione. C-NMR spectroscopic data of 3 were quite similar to those of 2 except that the oxymethine carbon signal at d 70.3 (C-15) in 2 was found to be upfield shifted to 67.6 ppm in compound 3. This was associated by the disappearance of the NMR signals of acetate and the IR absorption band of the ester group in 3. Thus, compound 3 was elucidated as the deacetyl derivative of 2. The relative configurations at C-1, C-4, C-9, and C-11 in compound 3 were found to be identical to those of 2 due to the same NOE correlations displayed in NOESY spectra of 2 and 3. On the basis of the above findings, the molecular framework of compound 5 was determined as shown in Fig. 1 . Furthermore, the analysis of the NOESY spectrum of 5 revealed 5 possesses the same relative configurations at C-1, C-4, C-5, C-9, and C-11 as those in 2-4. Thus, the relative structure of metabolite 5 was determined as (1S*,4S*,9R*,11S*)-xeniaphylla-8(19)-en-5,14-dione.
Gibberosin S (6) was found to possess a molecular formula C 24 C-NMR data of compound 6 with those of 2-5 revealed that 6 is also a 5-oxoxeniaphyllane with a trisubstituted double bond and two acetoxy groups in the side chain. The HMBC correlations ( ) further supported the C-14/C-15 position of the double bond. This double bond was determined to have a Z geometry on the basis of the NOE interaction found between H-14 and H 3 -17. Furthermore, the analysis of the NOESY spectrum of 6 revealed the similar stereochemistries at C-1, C-9, C-10, and C-11 as those in 2-5. Therefore, the relative structure of compound 6 was established as (1S*,4S*,9R*,11S*,14Z)-12,16-diacetoxyxeniaphylla-8(19),14-dien-5-one.
Sinugibberoside F (7) 3) The 1 H-and 13 C-NMR data of 7 spectra were very similar to those of a known compound sinugibberoside C (8), 2) except that a trisubstituted epoxide at C-4/C-5 in 8 was replaced by a trisubstituted double bond (d H 5.37, dd, Jϭ10.0, 9.5 Hz, H-5; d C 135.3, C, C-4; d C 124.5, CH, C-5) in 7. The molecular framework of 7 was further established by the 1 H-1 H COSY and HMBC correlations as illustrated in Fig. 1 . The E geometry of the 4,5-endocyclic double bond in 7 was indicated by the absence of NOE correlation between the olefinic methyl protons (d 1.60, s) attached at C-4 and H-5 (d 5.37, dd) and the upfield shift of C-20 (d 16.3). Further NOE analysis revealed that 7 possessed the same relative configurations at C-1, C-9, C-11, C-12, and C-15 as those of the known metabolite 8.
2) Based on the above results, the relative structure of 7 was determined as (1S*,9R*,11S*,12R*,15R*,4E)-12,15-epidioxy-xeniaphylla-4,8(19),13-trien-12,17-diol.
Cytotoxicity of metabolites 1-7 toward a limited panel of cancer cell lines was evaluated. Compound 2 was found to exhibit weak cytotoxicity toward Hep G2 (human hepatocellular carcinoma) and A549 (human lung carcinoma) cell lines with IC 50 's of 18.7 and 19.5 mg/ml, respectively. Also, metabolite 4 showed weak cytotoxicity (IC 50 11.0 mg/ml) toward A549 cells. Other metabolites were found to be inactive against the growth of the above three cancer cell lines.
